George Scangos' Bold Vision Post author:Sam Post published:October 24, 2017 Post category:BioPharma The former Biogen CEO is making waves at his new venture, Vir Biotechnology. Source: BioSpace You Might Also Like Astellas Takes Out Belgium Biotech in Deal Worth $853 Million April 2, 2017 On a Roll: FDA OKs Genentech's Gazyva for Untreated Follicular Lymphoma November 16, 2017 Why This Bay Area Biotech Could be a Cash Cow for Investors September 10, 2017
